Final report of University Hospital Hradec Kralove to the clinical trial protocol no. MK-0683-088

Abstract

Design of a part of a clinical trial called An International, Multicenter, Randomized, Double-Blind Study of Vorinostat (MK0683) or Placebo in Combination With Bortezomib in Patients With Multiple Myeloma

Keywords

• multiple myeloma
• vorinostat
• MK 0683
• bortezomib